Episode

GLP-1s and Cancer Part 3 - The Guardian Article

Podcast
Weight and Healthcare
Published
Jun 20, 2026
Duration seconds
532
Processing state
not_requested
Canonical source
https://weightandhealthcare.substack.com/p/glp-1s-and-cancer-part-3-the-guardian
Audio
https://api.substack.com/feed/podcast/202253940/ef6c18e5e6c02c00cdb9fcaf83980fb1.mp3
JSON
/v1/public/podcasts/weight-and-healthcare-6448206/episodes/glp-1s-and-cancer-part-3-the-guardian-article
Markdown
/podcast/weight-and-healthcare-6448206/glp-1s-and-cancer-part-3-the-guardian-article.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/weight-and-healthcare-6448206/episodes/glp-1s-and-cancer-part-3-the-guardian-article/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/weight-and-healthcare-6448206/glp-1s-and-cancer-part-3-the-guardian-article.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

In part 1 we discussed the basics around the current studies considering possible impacts of GLP-1s on cancer (if you haven’t read part 1 yet you might want to as I will refer to the things discussed in that post.) In part 2 we looked at a study that explored correlation between GLP-1 use and cis women with breast cancer. Today we’re going to look at a Guardian Article that many of you asked me to discuss. Get full access to Weight and Healthcare at weightandhealthcare.substack.com/subscribe